Last updated on October 2017

Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or S zary Syndrome (SS)


Brief description of study

The purpose of this study is to determine whether resminostat will be able to delay or prevent worsening of disease in patients with advanced stage mycosis fungoides or Sézary Syndrome that have recently achieved disease control with previous systemic therapy.

Clinical Study Identifier: NCT02953301

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Chief Medical Officer

Medizinische Universit t Graz
Graz, Austria
  Connect »

Chief Medical Officer

Medizinische Universit t Wien
Wien, Austria
  Connect »

Chief Medical Officer

Cliniques Universitaires Saint-Luc
Bruxelles, Belgium
  Connect »

Chief Medical Officer

Universitaire Ziekenhuizen
Leuven, Belgium
  Connect »

Chief Medical Officer

Centre Hospitalier Universitaire (CHU) de Bordeaux - H pital Saint-Andr
Bordeaux, France
  Connect »

Chief Medical Officer

CHU Estaing
Clermont-Ferrand, France
  Connect »

Chief Medical Officer

Centre Hospitalier Lyon-Sud
Lyon, France
  Connect »

Chief Medical Officer

Chu Paris-Gh St-Louis Lariboisiere F.Widal Hopital
Paris, France
  Connect »

Chief Medical Officer

Hopital Robert Debre - CHU de Reims
Reims, France
  Connect »

Chief Medical Officer

Charit - Universitaetsmedizin Berlin
Berlin, Germany
  Connect »

Chief Medical Officer

Universitaetsklinikum Bochum - St. Josef-Hospital
Bochum, Germany
  Connect »

Chief Medical Officer

Elbekliniken Buxtehude
Buxtehude, Germany
  Connect »

Chief Medical Officer

Uniklinik K ln
Cologne, Germany
  Connect »

Chief Medical Officer

Klinikum Dortmund
Dortmund, Germany
  Connect »

Chief Medical Officer

Helios Klinikum Erfurt
Erfurt, Germany
  Connect »

Chief Medical Officer

Universitaetsklinikum Essen
Essen, Germany
  Connect »

Chief Medical Officer

SRH Wald-Klinikum Gera
Gera, Germany
  Connect »

Chief Medical Officer

St dtisches Klinikum Karlsruhe
Karlsruhe, Germany
  Connect »

Chief Medical Officer

Universitaetsklinikum Schleswig-Holstein (UKSH), Campus Kiel
Kiel, Germany
  Connect »

Chief Medical Officer

HELIOS Klinikum
Krefeld, Germany
  Connect »

Chief Medical Officer

Klinikum der Stadt Ludwigshafen am Rhein
Ludwigshafen am Rhein, Germany
  Connect »

Chief Medical Officer

Universit tsklinikum Schleswig-Holstein
Lübeck, Germany
  Connect »

Chief Medical Officer

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz
Mainz, Germany
  Connect »

Chief Medical Officer

Universit tsklinikum Mannheim
Mannheim, Germany
  Connect »

Chief Medical Officer

Johannes Wesling Klinikum Minden
Minden, Germany
  Connect »

Chief Medical Officer

Ludwig-Maximilians-Universit t (LMU)
München, Germany
  Connect »

Chief Medical Officer

Universit ts-Hautklinik T bingen
Tübingen, Germany
  Connect »

Chief Medical Officer

Universit tsklinikum Ulm
Ulm, Germany
  Connect »

Chief Medical Officer

Universit tsklinikum W rzburg
Würzburg, Germany
  Connect »

Chief Medical Officer

Policlinico S.Orsola-Malpighi
Bologna, Italy
  Connect »

Chief Medical Officer

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milano, Italy
  Connect »

Chief Medical Officer

Universita Cattolica del Sacro Cuore
Roma, Italy
  Connect »

Chief Medical Officer

Ospedale Molinette
Turin, Italy
  Connect »

Chief Medical Officer

Leids Universitair Medisch Centrum (LUMC)
Leiden, Netherlands
  Connect »

Chief Medical Officer

Centrum Onkologii
Bydgoszcz, Poland
  Connect »

Chief Medical Officer

Medical University of Gdansk
Gdansk, Poland
  Connect »

Chief Medical Officer

SP ZOZ Szpital Uniwersytecki w Krakowie
Kraków, Poland
  Connect »

Chief Medical Officer

Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie
Warsaw, Poland
  Connect »